Efficacy and safety of PD-1/PD-L1 inhibitors in combination with chemotherapy or CAR-T cells for relapsed/refractory acute lymphoblastic leukemia: A multicenter phase ii trial
Adding PD-1 or PD-L1 blockade to either chemotherapy or CAR-T therapy improved clinical outcomes without excess toxicity in R/R ALL.
Authors
- Bolin Wan (ORCID: https://orcid.org/0009-0004-5318-0882)
- Min Zou
- Jing Hu (ORCID: https://orcid.org/0009-0002-3403-0534)
Institutions
- Ganzhou People's Hospital (CN)
Publication Details
- Journal
- Leukemia Research
- Published
- 2025-12-12
- DOI
- https://doi.org/10.1016/j.leukres.2025.108148
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 0.00